Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1963 1
1972 1
1973 1
1979 2
1981 2
1982 1
1983 2
1986 2
1987 3
1988 1
1989 2
1990 3
1991 3
1992 3
1993 2
1994 2
1995 4
1996 3
1997 3
1998 1
1999 2
2000 6
2001 6
2002 5
2003 11
2004 4
2005 4
2006 7
2007 5
2008 3
2009 8
2010 2
2011 1
2012 7
2013 7
2014 7
2015 6
2016 8
2017 2
2018 5
2020 1
2021 2
2022 5
2023 5
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW; Diabetic Retinopathy Clinical Research Network. Wells JA, et al. Among authors: hampton gr. Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27. Ophthalmology. 2016. PMID: 26935357 Free PMC article. Clinical Trial.
Challenges and Opportunities for Data Science in Women's Health.
Edwards TL, Greene CA, Piekos JA, Hellwege JN, Hampton G, Jasper EA, Velez Edwards DR. Edwards TL, et al. Among authors: hampton g. Annu Rev Biomed Data Sci. 2023 Aug 10;6:23-45. doi: 10.1146/annurev-biodatasci-020722-105958. Epub 2023 Apr 11. Annu Rev Biomed Data Sci. 2023. PMID: 37040736 Free PMC article. Review.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Viewing through the asteroids.
Hampton GR, Nelsen PT, Hay PB. Hampton GR, et al. Ophthalmology. 1981 Jul;88(7):669-72. doi: 10.1016/s0161-6420(81)34969-0. Ophthalmology. 1981. PMID: 7267035
Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in Diabetic Retinopathy in Protocol AA.
Writing Committee for the DRCR Retina Network; Ehlers JP, Josic K, Yordi S, Martin A, Srivastava SK, Sun JK. Writing Committee for the DRCR Retina Network, et al. Ophthalmol Retina. 2025 Mar;9(3):243-252. doi: 10.1016/j.oret.2024.08.015. Epub 2024 Aug 30. Ophthalmol Retina. 2025. PMID: 39216727
165 results